A study identified racial and ethnic disparities in survival among newly diagnosed patients with childhood cancers in the U.S., with area-level socioeconomic status and health insurance contributing to these disparities.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
